Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model

PURPOSE: We investigated the efficacy and optimal dosage of recombinant Bacillus Calmette-Guérin-dltA (rBCG-dltA) in a high-throughput 3D bio-printed bladder cancer-on-a-chip (BCOC) and orthotopic bladder cancer mouse model. MATERIALS AND METHODS: We fabricated high-throughput BCOC with microfluidic...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Joongwon, Jung, Tae Young, Kim, Jung Hoon, Maeng, Sejung, Kang, Su Jeong, Kim, Mirinae, Choi, Young Wook, Choi, Se Young, Kim, Sung-Hwan, Chang, In Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172047/
https://www.ncbi.nlm.nih.gov/pubmed/37341010
http://dx.doi.org/10.4111/icu.20220293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172047/
https://www.ncbi.nlm.nih.gov/pubmed/37341010
http://dx.doi.org/10.4111/icu.20220293

Ejemplares similares